Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Insulin
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Adagio
(insulin) / Aerami Therap, Hikma
NN1953
/ Novo Nordisk
HDV insulin lispro
(HDV-L) / Diasome
HR17031
/ Jiangsu Hengrui Pharma
BHT-3021
/ Bayhill Therap
BIOD 531
/ Ipsen
MK-3655
/ Merck (MSD)
Oshadi Icp
(insulin oral) / Oshadi Drug Administration
pramlintide/insulin A21G
(ADO09) / Adocia
tolimidone
(MTX228) / Bukwang Pharma, Biodexa Pharma
Capsulin
(oral insulin) / Diabetology
EX1000
/ Novo Nordisk
Ersatta
(mono-pegylated version of C-peptide) / Cebix
Insumera (long-acting basal insulin fused to ELP
(elastin-like polypeptide) biopolymer) / PhaseBio Pharma
LY900027
/ Eli Lilly
Nasulin
(intranasal insulin spray) / CPEX
S-707106
/ Shionogi
ultra-rapid-acting recombinant human insulin
(BIOD-123) / Ipsen
NT219
/ Purple Biotech
SAR 161271
/ Sanofi
Sansulin Log-G
(insulin glargine biosimilar) / Sanbe
bezafibrate/diflunisal
(CRx-401) / Sun Pharma
intranasal insulin
/ Adhera Therap
